Insider · CIK 0001977237
Robert R. Banks Jr.
Files at NEPH (NEPHROS INC). First filing -, latest -.
Robert R. Banks Jr. files SEC Form 4 as CEO and president at NEPH (NEPHROS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert R. Banks Jr. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | NEPH NEPHROS INC | MOption exercise Common Stock | +120,000 | $1.44 | $173k | 190,000 | Mar 25, 2026 |
| Mar 23, 2026 | NEPH NEPHROS INC | MOption exercise Stock Option (right to buy)derivative | -120,000 | $0.00 | $0 | 237,165 | Mar 25, 2026 |
Questions about Robert R. Banks Jr.
Answered from the filings on this page, as of the latest one.
Is Robert R. Banks Jr. buying or selling?
Robert R. Banks Jr. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert R. Banks Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert R. Banks Jr. has 0.
Where does Robert R. Banks Jr. file Form 4?
Robert R. Banks Jr. has filed Form 4 at NEPH (NEPHROS INC) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.